´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2. (Walk@Work)
Diabetes Mellitus, Type II

About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type II focused on measuring mHealth, Physical Activity, Glucose, Blood, Glycated Hemoglobin A1c, Health-Related Quality Of Life, Quality of Life, Triglycerides, HDL Cholesterol, LDL Cholesterol, Blood Pressure, Arterial, Presenteeism, Sitting time, Sedentary Behaviour, Workplace
Eligibility Criteria
Inclusion Criteria:
- DM2 diagnosed office employees according to international criteria.
- Doing sedentary tasks during at least a 55% of their daily work schedule (according to the Occupational Sedentary and Physical Activity Questionnaire: OSPAQ >55%).
- Having a cellphone .
- Having a minimum work contract of 18.5 hours per week.
- Being able to get up from the chair or to walk by themselves (without any help).
Exclusion Criteria:
- Not having a cellphone.
- Having some pathology/disability/injury which changes their ability and capacity to walk or getting up from the chair.
- Doing less than a 55% of the daily tasks in a sitting position according to the OSPAQ questionnaire.
Sites / Locations
- IDIAP Jordi GolRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Group
Control Group
In the intervention group, subjects will receive brief advice on occupational physical activity, sedentary behaviour and Diabetes Type 2. In addition, participants will be provided with an external movement sensor that will be linked to the Walk@WalkApp-Diab for Android and iOS. This App will monitor the time participants spend sitting, walking and standing during working hours. It will also provide participants with strategies to "sit less and move more" at work throughout 13 weeks. This mHealth intervention aims to change occupational sitting by replacing desk-based activities by active tasks.
Subjects will receive brief advice on occupational physical activity, sedentary behaviour and Diabetes Type 2.